• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HERAEUS MEDICAL GMBH PALACOS R+G; ORTHOPAEDIC BONE CEMENT, MEDICATED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HERAEUS MEDICAL GMBH PALACOS R+G; ORTHOPAEDIC BONE CEMENT, MEDICATED Back to Search Results
Catalog Number 66055102
Device Problem Biocompatibility (2886)
Patient Problems Hypersensitivity/Allergic reaction (1907); Low Blood Pressure/ Hypotension (1914); Tachycardia (2095); Hot Flashes/Flushes (2153)
Event Date 07/21/2023
Event Type  Injury  
Event Description
The patient underwent knee arthroplasty on (b)(6) 2023.After implantation of bone cement, the patient's blood pressure decreased to 75/50 mmhg, heart rate increased to 130 beats /min, and the skin was flushed.Chlormastine 1mg, epinephrine 0.5mg, methylprednisolone sodium succinate 40mg and other treatments were given.The patient had stable circulation, bp 125/63 mmhg, and heart rate 82 beats/min.The patient returned to the ward.
 
Manufacturer Narrative
It has been reported that a patient experienced a decrease in blood pressure to 75/50 mmhg, an increase in heart rate to 130 beats/min, and flushed skin following knee arthroplasty on (b)(6) 2023.The patient received treatment including chlormastine (an antihistamine) 1mg, epinephrine 0.5mg, methylprednisolone sodium succinate 40mg, and other interventions.After treatment, the patient's circulation stabilized with a blood pressure of 125/63 mmhg and a heart rate of 82 beats/min.The patient was then transferred back to the ward.This event is believed to be related to an allergic reaction, which is a known side effect.It is important to note that an allergic reaction to the components of the bone cement used during the procedure is a known side effect, and is addressed in the risk management file.The instructions for use (ifu) also provides information under the "contraindications" section, stating that "in cases of known hypersensitivity to the constituents of the bone cement palacos®r+g must not be used.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PALACOS R+G
Type of Device
ORTHOPAEDIC BONE CEMENT, MEDICATED
Manufacturer (Section D)
HERAEUS MEDICAL GMBH
philipp-reis-strasse 8/13
wehrheim, hesse 61273
GM  61273
Manufacturer (Section G)
HERAEUS MEDICAL GMBH
philipp-reis-strasse 8/13
wehrheim, hesse 61273
GM   61273
MDR Report Key17974640
MDR Text Key326128241
Report Number3006406161-2023-01020
Device Sequence Number1
Product Code MBB
Combination Product (y/n)Y
Reporter Country CodeCH
PMA/PMN Number
K202475N/A
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 10/20/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/20/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number66055102
Device Lot Number64661217
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/12/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age57 YR
Patient SexMale
Patient Weight72 KG
-
-